Clinical factors associated with high PD-L1 expression in patients with early-stage non-small cell lung cancer.

Shuta OharaKenichi SudaAkira HamadaMasato ChibaMasaoki ItoMasaki ShimojiToshiki TakemotoJunichi SohYasuhiro Tsutani

Published in: Thoracic cancer (2024)

These results showed that plasma fibrinogen, smoking history, and SUVmax are predictors of high PD-L1 expression, providing a basis for identifying patients expected to benefit from neoadjuvant ICI treatment.

Keyphrases

early stage
end stage renal disease
ejection fraction
newly diagnosed
rectal cancer
lymph node
prognostic factors
patient reported outcomes
neoadjuvant chemotherapy